← Back
$PVLA All transactions

PALVELLA THERAPEUTICS, INC.

M 10b5-1 Plan

$ Value

$0

Shares

2,154

Price

$0

Filed

Nov 21

Insider

Name

Goin Kathleen

Title

Chief Operating Officer

CIK

0001912570

Roles

Officer

Transaction Details

Transaction Date

2025-11-19

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,705

Footnotes

The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.475 to $86.08. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.485 to $86.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. | The stock option is fully vested.

Filing Info

Accession No.

0001104659-25-115017

Form Type

4

Issuer CIK

0001583648

Goin Kathleen's History

Date Ticker Type Value
2026-04-15 PVLA M $15K
2026-04-15 PVLA M $20K
2026-04-15 PVLA $189K
2026-04-15 PVLA $191K
2026-04-15 PVLA $72K
2026-04-15 PVLA $83K
2026-04-15 PVLA $13K
2026-04-15 PVLA M $0
2026-04-15 PVLA M $0
2026-03-18 PVLA M $15K

Other Insiders at PVLA (90d)

Insider Bought Sold Last
JENKINS GEORGE M $550K 2026-03-30
HERON ELAINE J $300K 2026-02-27
Korenberg Matthew E
CFO, Treasurer
2026-02-05
Goin Kathleen
Chief Operating Officer
$1.4M 2026-04-15
Doux John 2026-04-13
Martini Jeffrey S
Chief Scientific Officer
2026-02-05
Kaupinen Wes
President and CEO
2026-02-05
Kline Ashley Hartmann
Chief Commercial Officer
2026-02-05